Phase 1 study for Eloralintide and Terzepitide

yeddie

GLP-1 Apprentice
Member Since
Sep 15, 2025
Posts
88
Likes Received
192
Location
Ohio
United-States
David W at his blog has a new post about Eli Lilly releasing preliminary results for Eloralintide combined with Terzepitide. As expected it looks promising.

Eloralintide + Tirzepatide = Bariatric Surgery results!

(Yes, he's a fan.)

This is what Novo thought CagriSema could do.
These are short trials and in no way was there a weight plateau in any arm. This isn’t even the max potential weight loss with this combination. That being said I have a genuine concern that this weight loss is too rapid. Perhaps this is why Lilly has Enlighten-6 which combines eloralintide plus either semaglutide or tirzepatide AFTER you’ve stalled out on weight loss on either of those two agents first.
 
Nice!. are these actually new 2026 human data?

I've only seen the published 2025 eloralintide monotherapy results. Where did these combination numbers come from?

Are these from a conference abstract, a Lilly poster, an investor deck, or something else? I'd love to read the original source if anyone has a link.
 

Trending Topics

Forum Statistics

Threads
18,859
Posts
196,803
Members
62,833
Newest
Hortence
Back
Top Bottom